SpineGuard

Investors

Contact us

Investor Information

Stéphane Bette - Director, Co-Founder and Chief Executive Officer
Stéphane Bette,
Co founder and Deputy CEO
Pierre Jérôme,
Co founder, CEO & Chairman

Dear Shareholders,

SpineGuard’s management invites you to a webinar to discuss the company’s news, to review its partnerships, and to present its innovations as well as its perspectives on November 10th at 10:30 am. Register now.

Read the latest Financial News

Stock Information

Stock exchange information

  • ISIN code: FR0011464452
  • Stock Quote: ALSGD
  • Number of shares: 31.243.508
  • Sector: Medical technologies
  • Principal Index: Alternext All-share
  • Exchange: Euronext-Growth
  • Place of listing: Euronext Paris (France)
  • Eligibility to French PEA/SRD: Yes/No
  • Eligibility French PEA-PME: Yes

Financial agenda

  • 26 January 2022: 2021 Full-Year Sales
  • 27 January 2022: Investor Webinar
  • 28 April 2022: 2021 Full-Year Results
  • 28 April 2022: 2022 First-Quarter Sales
  • 8 June 2022: Annual Shareholders Meeting
  • 12 July 2022: 2022 First-Half Sales
  • 14 September 2022: 2022 First-Half Results
  • 12 October 2022: 2022 Third-Quarter Sales

Analysts

  • Biostrategic Research: Lionel Labourdette

Others

  • Liquidity contract: Tradition Securities And Futures (TSAF)
  • Auditors: Grant Thornton
  • Listing Sponsor: Swiss Life Banque Privée

Shareholders structure

(December 31th, 2021)

Chart by Visualizer

Stock quotes

  • To check the stock quote in real time, click here

For any request, don't hesitate to contact us

M